Elsevier

Cytokine

Volume 29, Issue 4, 21 February 2005, Pages 141-152
Cytokine

Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome

https://doi.org/10.1016/j.cyto.2004.10.013Get rights and content

Abstract

The aim of this study was to evaluate whether there was any correlation between Helicobacter pylori-associated diseases and (1) H. pylori virulence genes or (2) IL-1B, IL-1RN, IFN-G, TNF-A, IL-10 genetic polymorphisms. Patients with non-cardia gastric cancer (NCGC, n = 129) or benign gastroduodenal diseases (n = 792) were studied. IL-1RN intron 2 VNTR polymorphism (PCR), IL-1B −31 C/T (RFLP), the SNPs of IFN-G (+874 A/T), TNF-A (−1031 C/T, −857 C/T, −376 A/G, −308 A/G, −238 A/G), IL-10 (−1082 A/G, −819 C/T, −592 A/C) (Taqman chemistry) were studied. cagA, s1 and m1 vacA, were PCR amplified. Duodenal ulcer was more frequent in TNF-A −857 TT and in IL-1RN 1,2 subjects. TNF-A −857 TT genotype was also correlated with gastric ulcer. IL-10 −819 TT genotype was associated with intestinal metaplasia and NCGC. Antral inflammation was associated with TNF-A −1031 TT, while corpus activity with IL-10 −819 CC. H. pylori infection was associated with TNF-A −308 AG genotype, while IFN-G +874 AA genotype was associated with cagA. In conclusion, among host genetic factors contributing to H. pylori disease outcome, IFN-G +874 AA genotype favors cagA positive infections, TNF-A −857 TT duodenal ulcer while IL-10 −819 TT intestinal metaplasia and NCGC.

Introduction

Bacterial, environmental, population-related and individual host factors are major determinants of the outcome of Helicobacter pylori infection [1], [2], [3]. Many bacterial virulence genes, including the pathogenicity island cagA, the s1m1 vacA alleles, babA2, sabA and oipA, have been associated with a higher degree of gastric mucosal inflammation, intestinal metaplasia, gastric or duodenal ulcer, gastric adenocarcinoma and MALToma [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12]. H. pylori strains, on the other hand, lacking all the above genes, are considered low virulence bacteria or even non-pathogens. Irrespective of their specific genotype, all H. pylori strains colonize the human gastric mucosa, which become for them an “ecologic niche”: without appropriate pharmacological treatment, H. pylori persists in the stomach for decades [1], [2], [3], [13].

All H. pylori strains cause chronic gastric mucosal inflammation, characterized by the presence of infiltrating macrophages, B and T lymphocytes, polymorphonuclear cells and plasma cells [12], [14], [15]. H. pylori triggers and maintains gastric mucosal inflammation by different mechanisms, which are partly strain dependent and partly strain independent [2]. Among strain independent H. pylori pro-inflammatory triggering products, main determinants are Hp-NAP, a soluble protein which recruits and activates polymorphonuclear and mononuclear cells, and urease, which induces IL-8 secretion by gastric epithelial cells. The processing of H. pylori antigens is followed by the activation of T and B lymphocytes and by their infiltration of the gastric mucosa. The number of infiltrating polymorphonuclear cells varies depending on the virulence of the infecting strain, being much higher when infections are caused by cagA positive strains, although the main strain-associated inducer of the polymorphonuclear cell infiltrate is not cagA per se but cagA associated functional oipA [4], [10], [12], [15].

The inflammatory cells infiltrating H. pylori infected gastric mucosa, are not non-reactive elements: all make up the host machinery for clearing infection, and their activation is characterized by the production of a pattern of pro-inflammatory cytokines [13], [16], [17]. High mucosal levels of mononuclear [IL-8, IL-6, IL-1B, tumor necrosis factor alpha (TNF-A) and interferon gamma (IFN-G)] and lymphocytic derived cytokines (IL-2, IL-2R) have been described in H. pylori infected patients [16], [17], [18], [19], [20]. It has recently been suggested that the subclass of T lymphocytes, T helper 3, may influence the outcome of H. pylori infection by reducing the grade of inflammation via the production of IL-10 [21], [22].

Host cytokines gene polymorphisms may be as important as exogenous stimuli in influencing the number of cytokines produced and, consequently, the pattern and severity of inflammation [16], [23], [24], [25], [26], [27], [28], [29].

In a subset of H. pylori infected subjects, gastric mucosal inflammation might evolve through a series of intermediate steps, including intestinal metaplasia, into gastric adenocarcinoma [30], [31], the risk of which is higher in subjects infected with strains co-expressing cagA, s1 vacA and babA2 [2], [3], [6], [7], [12], [13], [16], [27], [31], although host cytokines gene polymorphisms, IL-1B, IL-1RN, TNF-A and IL-10 in particular, were suggested to be part of the genetic background predisposing to gastric adenocarcinoma in response to the carcinogen H. pylori [32], [33], [34], [35].

The aim of the present study was therefore to ascertain whether some genetic IL-1B, IL-1RN, IL-10, TNF-A and IFN-G polymorphisms are associated with H. pylori infection, H. pylori disease outcome and the pattern and severity of H. pylori-associated gastric mucosal inflammation.

Section snippets

H. pylori infection, virulence genes and diagnosis

H. pylori infection, established on the basis of histology, and documented in 406/792 patients without non-cardia gastric cancer, was significantly associated with disease diagnosis (χ2 = 70.45, p < 0.001). Positive results were found in 88 (76%) duodenal ulcer, 21 (66%) gastric ulcer and in 297 (46%) patients belonging to the reference group, which comprised patients with benign esophageal and/or gastric and/or duodenal inflammation, but without non-cardia gastric cancer or gastric or duodenal

Discussion

H. pylori-associated diseases depend on H. pylori virulence genes and the host genetic background, which is suggested to have an influence in determining the susceptibility to H. pylori infection, its maintenance and outcome [16], [26], [27], [28], [32], [33], [34], [35], [36], [37], [38], [39]. Among the host determinants of H. pylori-associated disease outcome, the balance between pro-inflammatory and anti-inflammatory cytokines seems to play a major role. Host genetic polymorphisms of

Patients

We studied 792 unrelated Italian patients (362 males, 430 females; age range 17–94 yrs) who consecutively underwent upper gastrointestinal endoscopy (EGDS) for dyspeptic symptoms. Diagnoses, made on the basis of endoscopic findings, were: gastric ulcer (16 males, 16 females, age range 26–85 yrs), duodenal ulcer (76 males, 40 females, age range 17–78 yrs), antral gastritis (76 males, 125 females, age range 18–79 yrs), diffuse gastritis (57 males, 111 females, age range 21–94 yrs), reflux

References (50)

  • E.M. El-Omar et al.

    Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms

    Gastroenterology

    (2003)
  • S. Take et al.

    Interleukin-1β genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection

    Am J Gastroenterol

    (2003)
  • T. Thye et al.

    Genomewide linkage analysis identifies polymorphisms in the human interferon-g receptor affecting Helicobacter pylori infection

    Am J Hum Genet

    (2003)
  • W.H. Jang et al.

    The −238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers

    Cancer Lett

    (2001)
  • L. Morris Brown

    Helicobacter pylori: epidemiology and routes of transmission

    Epidemiol Rev

    (2000)
  • C. Montecucco et al.

    Living dangerously: how Helicobacter pylori survives in the human stomach

    Nature Rev

    (2001)
  • M.F. Go

    Review article: natural history and epidemiology of Helicobacter pylori infection

    Aliment Pharmacol Ther

    (2002)
  • D. Basso et al.

    Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenla diseases

    Gut

    (1998)
  • Y. Yamaoka et al.

    Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries

    J Clin Microbiol

    (1999)
  • D.Y. Graham et al.

    Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise

    Helicobacter

    (2000)
  • C. Prinz et al.

    Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation

    Cancer Res

    (2001)
  • Y. Yamaoka et al.

    A Mr 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori

    Proc Natl Acad Sci U S A

    (2000)
  • J. Mahdavi et al.

    Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation

    Science

    (2002)
  • C.-F. Zambon et al.

    Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia

    J Clin Pathol

    (2003)
  • S. Suerbaum et al.

    Helicobacter pylori infection

    N Engl J Med

    (2002)
  • Cited by (191)

    • Host-Microbiome Interactions in Gastrointestinal Cancers

      2023, Microbiome in Gastrointestinal Cancer
    View all citing articles on Scopus
    1

    Reprint requests for materials should be addressed to Prof. Mario Plebani. Tel.: +39 0498212792; fax: +39 049663240.

    View full text